Launch · Enterprise Software & IT

SwishX launches agentic AI platform for pharma

What they do

SwishX builds agentic AI to automate sales, marketing, tender management and hospital contracts for pharma and medtech

It launched the platform and raised a $2.2 million seed round from Powerhouse Ventures, Blume Ventures, Sadev Ventures and Atrium Ventures

The company pivoted from IT asset management (Swish Club) and now targets $5 million ARR and 100+ enterprise clients by end FY 2026-27

SwishX launched the world's first agentic AI platform for pharma and medtech on 12 May 2026.
The platform automates sales, marketing, distribution, tender management, hospital rate contracts and commercial workflows.
It raised a $2.2 million seed round from Powerhouse Ventures, Blume Ventures, Sadev Ventures and Atrium Ventures.
The company was formerly Swish Club, an IT asset management platform, and rebranded to SwishX after pivoting.
As Swish Club, it had raised $4.5 million in previous funding.
During the transition, SwishX let go of sales teams and ramped up engineering.
The platform includes four products: Tender IQ, Contract IQ, Marketing IQ and Channel IQ.
SwishX plans to raise a larger funding round in the future.

Pharma commercial decisions currently rely on spreadsheets, disconnected software and manual workflows, causing delayed reporting.
India is the 'pharmacy of the world', supplying 20% of global medicines and exporting to over 200 countries.
The emerging markets plus India pharma and medtech opportunity is $400 billion, growing to $770 billion by 2033 at a CAGR over 12%.
AI in healthcare and life sciences globally is valued at $60-110 billion annually.
The pivot from IT asset management was driven by capital intensity and difficulty scaling beyond India.

SwishX builds agentic AI that captures siloed data, automates workflows, learns decision nuances and builds functional memory.
It positions itself as a 'system of action', not a 'system of record'.
Tender IQ automates tender and RFP analysis, evaluating thousands of tenders and identifying high-probability wins.
It analyzes documents exceeding 500 pages, recommends pricing and drafts proposals in minutes.
Contract IQ automates hospital rate contract management and reduces price leakage by 15%.
Marketing IQ converts marketing PDFs into personalized video reels for doctors, reducing production time from weeks to one day.
It has a database of over 8,00,000 verified doctors and increased brand visibility by 32% within six months.
Channel IQ provides real-time visibility into secondary sales, stockist ordering patterns and distributor compliance.
The platform is ISO 27001 certified, SOC 2 Type 2 compliant and GDPR-aligned, with data encrypted in transit and rest.
It embeds UCPMP and Section 194R compliance in marketing workflows and keeps a human-in-the-loop for final decisions.
Pricing is SaaS subscription-based, with individual modules, free trials and pilot programmes.
SwishX currently has 39 enterprise customers, 12 with annual revenue over ₹1,000 crore.
Its long-term vision is a vertically integrated AI for the life sciences value chain, including drug discovery and biosimilar development.

SwishX plans to expand into Latin America, Southeast Asia, Middle East, Africa and Eastern Europe.
It aims to reach $5 million contracted ARR and 100+ enterprise clients by end FY 2026-27.
The company plans to raise a larger funding round in the future.